Long term efficacy and tolerability of indiplon-ir in the treatment of chronic insomnia: Results of a double-blind, placebo-controlled 3-month study

被引：0
|
作者：
Scharf, MB
Black, J
Hull, S
Mahowald, M
Moscovitch, A
Farber, R
Jochelson, P
机构：
[1] Tri State Sleep Disorders Ctr, Cincinnati, OH USA
[2] Sleep Clin San Francisco, San Francisco, CA USA
[3] Vince & Associates Clin Res, Overland Pk, KS USA
[4] Minnesota Reg Sleep Disorders Ctr, Minneapolis, MN USA
[5] CSI Res Ctr, Calgary, AB, Canada
[6] Neurocrine Biosci, San Diego, CA USA
来源：
SLEEP | 2005年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
682
引用
收藏
页码：A229 / A229
页数：1
相关论文
共 50 条
  • [1] Long-term nightly treatment with indiplon in adults with chronic insomnia: Results of a double-blind, placebo-controlled, 3-month study
    Farber, R
    Scharf, MB
    Black, J
    Landin, R
    NEUROLOGY, 2006, 66 (05) : A9 - A9
  • [2] Long-term nightly treatment with indiplon in adults with primary insomnia: Results of a double-blind, placebo-controlled, 3-month study
    Scharf, Martin B.
    Black, Jed
    Hull, Steven
    Landin, Rick
    Farber, Robert
    SLEEP, 2007, 30 (06) : 743 - 752
  • [3] Efficacy and tolerability of indiplon in adults with chronic insomnia: Results from two double-blind, placebo-controlled trials
    Klee, B.
    Keohane, D.
    Bell, J.
    Farber, R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 48 - 48
  • [4] Efficacy and tolerability of indiplon in primary insomnia: Results of a double-blind, placebo-controlled, 4-week trial
    Lankford, D.
    Klee, B.
    Kean, Y.
    Farber, R.
    SLEEP, 2006, 29 : A256 - A256
  • [5] Efficacy and tolerability of gaboxadol in adults with primary insomnia: A 3-month, randomized, double-blind, placebo-controlled trial
    Anderson, D.
    Roth, T.
    Zheng, Y.
    Vandormael, K.
    Smith, A.
    Li, M.
    Digravio, D.
    SLEEP, 2007, 30 : A234 - A234
  • [6] Efficacy and tolerability of Indiplon-MR in elderly patients with chronic insomnia: Results of a double-blind, placebo-controlled, 2-week trial
    Lankford, J
    Lydiard, R
    Walsh, JK
    Seiden, D
    Jochelson, P
    SLEEP, 2005, 28 : A230 - A230
  • [7] Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis - A double-blind, placebo-controlled study
    Meister, R
    Wittig, T
    Beuscher, N
    de Mey, C
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1999, 49 (04): : 351 - 358
  • [8] Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial
    Lydiard, R. Bruce
    Lankford, D. Alan
    Seiden, David J.
    Landin, Rick
    Farber, Robert
    Walsh, James K.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2006, 2 (03): : 309 - 315
  • [9] Phase 3 Placebo-Controlled Study of Galcanezumab in Patients with Chronic Cluster Headache: Results from 3-Month Double-Blind Treatment
    Oakes, T. M.
    Dodick, D. W.
    Goadsby, P. J.
    Lucas, C.
    Jensen, R.
    Bardos, J.
    Martinez, J.
    Zhou, C.
    Aurora, S. K.
    Yang, J.
    Conley, R.
    HEADACHE, 2019, 59 : 19 - 20
  • [10] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 6-month double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    SLEEP, 2007, 30 : A252 - A253
12345